At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
Indego Exoskeletondevice
Likely dose
Indego exoskeleton training: five training sessions over two weeksAI-extracted
Key inclusion· 10
- ✓History of one sided ischemic or hemorrhagic stroke with resultant hemiparesis
- ✓Manual Muscle Test (MMT) 4/5 in at least upper extremity
- ✓No other brain abnormalities or neurological diseases/disorders
- ✓Only one stroke diagnosis (not multiple strokes)
Key exclusion· 5
- ✕Multiple prior strokes
- ✕Pregnancy
- ✕Colostomy bag
- ✕Uncontrolled or untreated hypertension or hypotension
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
In Brief
A clinical study evaluating Indego Exoskeleton for Cerebrovascular Accident (CVA) and 2 related conditions. Completed, enrolled 48 participants across 7 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Accident (CVA), Stroke, Hemiplegia
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartFeb 2017
Primary CompletionDec 2017
Study CompletionJan 2018
TodayJul 2026
First PostedFeb 15, 2017
Enrollment StartFeb 21, 2017
Primary CompletionDec 28, 2017
Study CompletionJan 17, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.4 years ago
Interventions
Indego Exoskeletondevice
Six study sessions including five Indego training sessions over two weeks.